The Scientist - Home

Gold in That Thar Crater Where Credits Are Due Garden of E-Mail WHI Expands Survival Center Power Lines Bibliographers' Competition Date: November 14, 1994, pp.25 In today's overpublished research environment, what kind of work captures the world's attention? Los Alamos National Laboratory geologist Fraser Goff has an answer. Last month, at the Geological Society of America's annual meeting in Seattle, he presented a paper report

"Lots of companies come out with media or reagents for this or that, and make a big splash, but they're all basically derivatives of traditional products," says Hayden Coon, a former National Institutes of Health re-searcher who is the founder of Human Cell Therapies Inc. of Chebeague Island, Maine. Advanced Biotechnologies Inc. Columbia, MD American Qualex Antibodies La Mirada, CA American Type Culture Collection (ATCC) Rockv

From December 10 through 14, organizers expect approximately 7,000 researchers to gather in San Francisco for the 34th annual meeting of the American Society for Cell Biology. More than 2,800 presentations and posters, as well as a trade show representing more than 300 organizations are scheduled. Following are some of the special events scheduled to take place at the convention: Saturday, December 10, 10:00 a.m. to 5:00 p.m.: P

At a September 9 meeting in Geneva, the 10-member WHO Ad Hoc Committee on Orthopoxvirus Infections unanimously agreed that the potential costs to humanity from biological warfare or inadvertent outbreaks of the disease outweigh its research benefits to Science--especially when there are alternatives to using the live virus for scientific investigations. Advocates of preserving the viral stores argue, however, that given the powerfu

According to the polling organization, the 1,254 respondents' age, sex, race, education, and region were weighted "to bring them into line with their actual proportions in the population." The margin of error for the survey is approximately 3 percent. Following are highlights of the survey: 91 percent of respondents said they believed the U.S. should spend more on medical research. Given a choice, 61 percent said the country shoul

"Gallo's meeting has juice, that's what it's got," declares Cecil H. Fox, an experimental pathologist, biochemist, and 20-year NIH veteran who is now president of Molecular Histology Laboratories Inc., Gaithersburg, Md. "That is, there's a lot of interpersonal contact, there are colorful people that go to it, there are discussions, disagreements, and, frequently, hard feelings and good feelings that come out of it. It's what scienti

"We are trying to make a statistics program that everyone can use, and Windows, in particular, is helping us do that," says Paul Portrey, assistant manager of technical support at Stat-Soft Inc. in Tulsa, Okla. "If developers take advantage of the features of Windows, they can make a package that's very easy to work with." Windows is not an operating system but an add-on to the DOS operating system that drives IBM and compatible PCs

In 1993, the Food and Drug Administration (FDA) declined to approve Malvern, Pa.-based Centocor Inc.'s lead compound, Centoxin, sending the company into a near-fatal financial tailspin. Today, after a drastic retrenching, Centocor has recovered to be listed as one of the top 10 biotechnology firms by market valuation in the Ernst and Young report "Biotech '95: Reform, Restruc- ture, Renewal." A new angioplasty therapeutic called R

President Clinton's choices for the winners of the 1994-95 Enrico Fermi Award--Freeman Dyson, a professor, emeritus, of physics at the Institute for Advanced Study in Princeton, N.J., and Liane B. Russell, a geneticist who is a senior corporate fellow at the Oak Ridge National Laboratory in Tennessee--reflect a changing attitude on the part of the United States government about the benefits of nuclear power, say some scientists. Th

The program, called the Joint and Co-Sponsored U.N. Program on HIV/AIDS, was first proposed by the World Health Organization's (WHO) executive board of directors in January of this year. It was given final approval by the U.N. Economic and Social Council last month. Expected to be fully functional by January 1996, the program would link AIDS-related activities of six participating organizations: WHO; the World Bank; the U.N. Educati

The World Health Organization (WHO), based in Geneva, will back large-scale clinical trials of two experimental HIV vaccines that failed earlier this year to win similar approval in the United States. In June, Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), chose not to support the complex and costly trials because "the science wasn't there to justify it." Each vaccine relies on stimul

David M. Goldenberg, president of the Garden State Cancer Center, a cancer research institution in Newark, N.J., and Jean-Pierre Mach, a professor of biochemistry in the faculty of medicine at Lausanne University, Switzerland--were honored last month with the 1994 Abbott Award. The award was presented at the 22nd meeting of the International Society for Oncodevelopmental Biology (ISOBM), held in Groningen, the Netherlands. ISOBM, cu